Chair: Ichiro Nakashima (Division of Neurology, Tohoku Medical and Pharmaceutical University Professor – Sendai, Japan)
Kesimpta – latest data from ECTRIMS 2025
Bernd Kieseier (Global Program Head, Drug Development, Novartis AG, Switzerland, Professor of Neurology at the Heinrich Heine University – Düsseldorf, Germany)